BioCentury
ARTICLE | Financial News

Hua raises $110.5M in HK IPO, trades flat on first day

September 14, 2018 7:16 PM UTC

Hua Medicine Ltd. (HKSE:2552) shares ended the day unchanged at HK$8.28 in the company's first day of trading Sept. 14. The diabetes play raised HK$867 million ($110.5 million) in an IPO through the sale of 104.8 million shares at HK$8.28, valuing the company at HK$8.7 billion ($1.1 billion).

The offering priced at the low end of its HK$8.28-HK$9.28 range. Underwriters were Goldman Sachs, CLSA, UBS and Guotai Junan International...

BCIQ Target Profiles

Glucokinase (GCK) (GK)